Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

Editorial: liver transplantation for primary biliary cholangitis-the need for timely and more effective treatments

(2019) Alessio Gerussi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

(2018) Christophe Corpechot et al.   NEW ENGLAND JOURNAL OF MEDICINE

Letter: reduction in projected mortality or need for liver transplantation associated with bezafibrate add-on in primary biliary cholangitis with incomplete UDCA response

(2018) Christophe Corpechot et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Noninvasive markers for staging fibrosis in chronic delta hepatitis

(2016) V. Takyar et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

(2016) Frederik Nevens et al.   NEW ENGLAND JOURNAL OF MEDICINE

Non-Invasive Assessment of Liver Fibrosis Progression and Prognosis in Primary Biliary Cholangitis

(2015) Raoul Poupon   DIGESTIVE DISEASES

Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

(2015) Willem J. Lammers et al.   GASTROENTEROLOGY

EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis

(2015)   JOURNAL OF HEPATOLOGY

Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study

(2014) Willem J. Lammers et al.   GASTROENTEROLOGY

Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response

(2014) Palak J. Trivedi et al.   JOURNAL OF HEPATOLOGY

Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection

(2013) Roger Chou et al.   ANNALS OF INTERNAL MEDICINE

Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients

(2013) Craig Lammert et al.   JOURNAL OF GASTROENTEROLOGY

Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis

(2012) Christophe Corpechot et al.   HEPATOLOGY

Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease

(2011) Leon A Adams et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome

(2011) Christophe Corpechot et al.   JOURNAL OF HEPATOLOGY

A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre

(2010) Annarosa Floreani et al.   LIVER INTERNATIONAL

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology

Predictive Value of Aspartate Aminotransferase to Alanine Aminotransferase Ratio for Hepatic Fibrosis and Clinical Adverse Outcomes in Patients With Primary Biliary Cirrhosis

(2009) Chien-Wei Su et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Biochemical markers for non-invasive assessment of disease stage in patients with primary biliary cirrhosis

(2009) Tamara Alempijevic et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay

(2008) Marlyn J. Mayo et al.   HEPATOLOGY

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

(2008) Christophe Corpechot et al.   HEPATOLOGY

Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B

(2007) W.G. Shin et al.   DIGESTIVE AND LIVER DISEASE